Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

275.25 -1.90 (-0.69%)
Streaming Delayed Price Updated: 2:09 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
37 38 Next >
News headline image
Combatting the Loneliness Epidemic: The Role of Muah AI in Providing Emotional Support
Combatting the Loneliness Epidemic: The Role of Muah AI in Providing Emotional Support 
Via News Direct
Topics Artificial Intelligence
News headline image
Despite its growth, NYSE:CI remains within the realm of affordability. ↗
In the world of growth stocks, NYSE:CI shines as a value proposition. 
Via Chartmill
News headline image
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability ↗
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance... 
Via Benzinga
Top-rated Medicaid Practice, Denver Youth Dentistry and Orthodontics Removes Barriers to Quality Dental Care for Children in Denver
Via Get News
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,700 Today ↗
 
Via Benzinga
News headline image
Forecasting The Future: 12 Analyst Projections For Cigna Group ↗
 
Via Benzinga
News headline image
NYSE:CI, a growth stock which is not overvalued. ↗
THE CIGNA GROUP (NYSE:CI) is not too expensive for the growth it is showing. 
Via Chartmill
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,800 Today ↗
 
Via Benzinga
News headline image
Class Lawsuit Alleges Cigna Discriminates by Excluding Obesity Drugs
June 05, 2024 -- Nation's First Lawsuit Asserting that the Affordable Care Act Forbids Exclusion of Obesity Treatment 
Via 24-7 Press Release
Topics Lawsuit
News headline image
Centene Reaffirms Guidance, But Is it Too Late?
Managed care health insurance company Centene Inc. (NYSE: CNC) recently saw its share rebound after reaffirming its guidance. This move came 
Via MarketBeat
News headline image
Is Cigna Group the Nation's Best-Run Health Insurance Company?
Cigna looks like a shining star as many health insurance companies fare poorly in 2024 due to higher Medicare Advantage (MA) expenses 
Via MarketBeat
News headline image
2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips? ↗
The major market indexes keep hitting new highs, but these stocks haven't participated in the bull run. 
Via The Motley Fool
News headline image
NYSE:CI is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗
THE CIGNA GROUP (NYSE:CI) is an undervalued gem with solid fundamentals. 
Via Chartmill
News headline image
Looking Into Cigna Group's Recent Short Interest ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $16,000 Today ↗
 
Via Benzinga
News headline image
Cigna Group's Options: A Look at What the Big Money is Thinking ↗
 
Via Benzinga
News headline image
Gravy Train Investing ↗
Today, let’s discuss policy investing. Or, if you prefer, feel free to call it “gravy train investing.” And it can be very profitable. 
Via Talk Markets
News headline image
Cigna Stock Hovers Near All-time High Amid Healthy Profit Growth ↗
Cigna stock is building a flat base with a 365.71 buy point., which is also its all-time high, set on March 28. 
Via Investor's Business Daily
News headline image
Buffett’s Best Bets: 3 Must-Have Stocks in the Oracle’s Arsenal ↗
Chubb, Liberty Media and Bank of America are three Warren Buffett stocks to buy for investors seeking long-term opportunities. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
How to Win in Business: Be Right, Be Positive ↗
Author Elliott Parker helps us think about how to spot the difference between world-changing innovations and corporate theater. 
Via The Motley Fool
News headline image
NYSE:CI stands out as a growth opportunity that won't break the bank. ↗
Don't overlook THE CIGNA GROUP (NYSE:CI)—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
News headline image
NYSE:CI stands out as a stock that provides good value for the fundamentals it showcases. ↗
THE CIGNA GROUP (NYSE:CI) appears to be flying under the radar despite its strong fundamentals. 
Via Chartmill
News headline image
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday? ↗
U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains. 
Via Benzinga
Topics Economy
News headline image
Cigna Group (CI) Q1 2024 Earnings Call Transcript ↗
CI earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Cigna Crushes Q1 Estimates: Revenue Soars With Evernorth's Explosive Growth ↗
Cigna beats sales expectations with a 23% Y/Y increase to $57.26 billion, driven by Evernorth Health Services' growth and strong contributions from Cigna Healthcare. Explore financial insights and... 
Via Benzinga
News headline image
CI Stock Earnings: Cigna Group Beats EPS, Beats Revenue for Q1 2024 ↗
CI stock results show that Cigna Group beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
Health insurer Humana reported Q1 2024 earnings, getting a less dramatic reaction than its Q4 2023 report, causing shares to tumble more than 13%. 
Via MarketBeat
News headline image
3 Dirt-Cheap Health Stocks to Buy on Weakness ↗
The managed care stocks look far too cheap for investors seeking health exposure at a relatively low price of admission. 
Via InvestorPlace
News headline image
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost ↗
Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of $3,500 yearly. 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.